- Описание
-
Product Information
Description
SARS-CoV-2 spike glycoprotein mouse monoclonal
Protein full name
SARS-COV-2 S protein S1 subunit RBD
domain
Synonyms
SARS-COV-2 S protein S1, RBD,
SARS-CoV-2 spike glycoprotein,
ARS-CoV-2 S protein RBD, Covid-19
Immunogen
SARS-COV-2 S protein S1 subunit RBD
domain recombinant protein expressed in
293F cells.
Isotype
IgG
Purity
Affinity purification
Predicted MW.
25 kDa
Observed MW.
25 kDa/35 kDa (glycosylation)
Applications
Applications
Species
Dilution
Positive Tissue
WB
-----------
1: 500-1: 1000
Use at an assay dependent sample
Elisa
-----------
1: 500-1: 20000
-----------
Background
SARS-COV-2 S protein S1 is a powerful weapon of coronavirus SARS-COV-2 to infect human normal cell. Because the receptor binding domain (RBD) lies in S spike protein S1 subunit, which exclusively binds to human ACES2 protein, followed by SARS-COV-2 nuclear materials entering into human cells cytoplasm and starting replication.
Images
Western blot analysis of SARS-COV-2 S protein S1 (GB12869) at dilution of 1:600.
Lane 1-3: recombination RBD protein expressed in 293F cells

Binding Activity of GB12869 with SARS-COV-2 S protein S1. Activity: Measured by its binding ability in a functional ELISA. Immobilized
SARS-COV-2 S protein S1 at 1 μg/ml can bind GB12869. The EC50 of GB12869 is 7.67 ng/ml.
Storage
Storage Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles. Storage Buffer PBS with 0.02%sodium azide,100 μg/ml BSA and 50% glycerol. NOTE:
1.This product is intended for research only.
2.This product is recommended to dilute with the Primary Antibody Dilution Buffer (G2025).







